Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 01, 2022

SELL
$33.11 - $55.01 $1.9 Million - $3.16 Million
-57,417 Closed
0 $0
Q3 2021

Nov 05, 2021

SELL
$50.07 - $66.05 $122,671 - $161,822
-2,450 Reduced 4.09%
57,417 $2.88 Million
Q2 2021

Jul 30, 2021

SELL
$56.61 - $80.46 $312,543 - $444,219
-5,521 Reduced 8.44%
59,867 $3.77 Million
Q1 2021

May 12, 2021

SELL
$86.23 - $125.19 $39.3 Million - $57 Million
-455,426 Reduced 87.45%
65,388 $6.08 Million
Q1 2021

May 04, 2021

BUY
$86.23 - $125.19 $39.4 Million - $57.2 Million
456,931 Added 715.26%
520,814 $48.4 Million
Q4 2020

Feb 03, 2021

BUY
$79.17 - $111.47 $5.06 Million - $7.12 Million
63,883 New
63,883 $5.72 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $473M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Oak Ridge Investments LLC Portfolio

Follow Oak Ridge Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Ridge Investments LLC with notifications on news.